Investigating imaging and blood markers to improve prostate cancer treatment outcomes
Longitudinal Imaging and Liquid Biopsy Markers of Prostate Cancer Radiotherapy Outcomes
This study is looking to help men with intermediate and high-risk prostate cancer who are getting radiation treatment by finding early signs that show how well the treatment is working, using special imaging and blood tests, so doctors can make better decisions about their care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11168073 on NIH RePORTER |
What this research studies
This research focuses on improving treatment outcomes for intermediate and high-risk prostate cancer patients undergoing radiotherapy. It aims to identify early indicators of treatment response by using advanced imaging techniques and analyzing circulating tumor cells in the blood. By combining these methods, the study seeks to better understand how different tumor characteristics affect patient outcomes and optimize treatment strategies. Patients will be monitored over time to assess the effectiveness of these markers in predicting progression and guiding therapy decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with intermediate to high-risk nonmetastatic prostate cancer who are candidates for radiotherapy.
Not a fit: Patients with low-risk prostate cancer or those who are not candidates for radiotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment plans for prostate cancer patients, potentially reducing the risk of disease progression.
How similar studies have performed: Previous research has shown promise in using imaging and liquid biopsy markers to predict treatment outcomes in cancer, suggesting that this approach may yield valuable insights.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Pollack, Alan — University of Miami School of Medicine
- Study coordinator: Pollack, Alan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.